KristenKeonCiomborMD

Oncology • Nashville, TN

Gastrointestinal Cancer, Hematologic Oncology

Assistant Professor of Medical Oncology

Join to view full profile

Dr. Ciombor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ciombor's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-936-2000

Fax+1 615-936-0605

Education & Training

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2013
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2005 - 2009
University of Miami Leonard M. Miller School of MedicineClass of 2005

Certifications & Licensure

TN State Medical License 2017 - 2026
AL State Medical License 2020 - 2020
OH State Medical License 2013 - 2019
FL State Medical License 2008 - 2010
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations Start of enrollment: 2020 Aug 31
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

Patient-Reported Discussions on Fertility Preservation Before Early-Onset Cancer Treatment.
Samantha R Keller, Allison Rosen, Mark A Lewis, Hyo K Park, Rebecca Babyak
JAMA Network Open. 2024-11-04
Discovery and validation of a 10-gene predictive signature for response to adjuvant chemotherapy in stage II and III colon cancer.
Chaohan Xu, Peng Xia, Jie Li, Keeli B Lewis, Kristen K Ciombor
Cell Reports. Medicine. 2024-08-20
8 citations
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.
Al B Benson, Alan P Venook, Mohamed Adam, George Chang, Yi-Jen Chen
Journal of the National Comprehensive Cancer Network. 2024-08-01

Lectures

NuTide: 302—A phase Ib study of the ProTide NUC-3373 in combination with standard therapies in advanced colorectal cancer.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Press Mentions

Only Half of Young Cancer Patients Report a Discussion on Fertility PreservationNovember 12th, 2024
Underpinning the Advances, Challenges to Democratizing Precision OncologyDecember 3rd, 2022
Ciombor Chosen for NCI Clinical Investigator Team Leadership AwardJuly 15th, 2021
Join now to see all

Professional Memberships